Anti-cancer Protein, Once Reactivated, Seen to Target Ovarian Cancer Cells in Early Study

Anti-cancer Protein, Once Reactivated, Seen to Target Ovarian Cancer Cells in Early Study
Researchers have discovered how reactivating a protein called OPCML — a tumor suppressor molecule usually reduced or lost in cancer patients — works to suppress ovarian cancer cells. These findings may lead to OPCML-based therapies to fight this cancer. The preclinical study reporting the findings, “The tumour suppressor OPCML promotes AXL inactivation by the phosphatase

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *